{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:14:30Z","timestamp":1770974070734,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T00:00:00Z","timestamp":1453248000000},"content-version":"vor","delay-in-days":384,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["biophysj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Journal"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.bpj.2014.11.3460","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T17:06:30Z","timestamp":1421773590000},"page":"272-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Effect of Thanatophoric Dysplasia Type I Mutations on FGFR3 Dimerization"],"prefix":"10.1016","volume":"108","author":[{"given":"Nuala","family":"Del\u00a0Piccolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Placone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalina","family":"Hristova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpj.2014.11.3460_bib1","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/ajmg.a.31368","article-title":"The new bone biology: pathologic, molecular, and clinical correlates","volume":"140","author":"Cohen","year":"2006","journal-title":"Am. J. Med. Genet.\u00a0A."},{"key":"10.1016\/j.bpj.2014.11.3460_bib2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ajmg.10780","article-title":"Some chondrodysplasias with short limbs: molecular perspectives","volume":"112","author":"Cohen","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bpj.2014.11.3460_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2","article-title":"Clinical spectrum of fibroblast growth factor receptor mutations","volume":"14","author":"Passos-Bueno","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bpj.2014.11.3460_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/hmg\/5.4.509","article-title":"Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)","volume":"5","author":"Rousseau","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bpj.2014.11.3460_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.yexcr.2004.11.012","article-title":"Cell responses to FGFR3 signaling: growth, differentiation and apoptosis","volume":"304","author":"L'Horte","year":"2005","journal-title":"Experim. Cell Res."},{"key":"10.1016\/j.bpj.2014.11.3460_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bpj.2014.11.3460_bib7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.2002.17.5.860","article-title":"Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization","volume":"17","author":"Adar","year":"2002","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.bpj.2014.11.3460_bib8","first-page":"71","article-title":"Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I","volume":"9","author":"d\u2019Avis","year":"1998","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.bpj.2014.11.3460_bib9","doi-asserted-by":"crossref","first-page":"e3961","DOI":"10.1371\/journal.pone.0003961","article-title":"Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage","volume":"3","author":"Krejci","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bpj.2014.11.3460_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bpj.2014.11.3460_bib11","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1111\/j.1742-4658.2007.05835.x","article-title":"The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor","volume":"274","author":"Bonaventure","year":"2007","journal-title":"FEBS\u00a0J."},{"key":"10.1016\/j.bpj.2014.11.3460_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00774-008-0009-7","article-title":"FGFR3-related dwarfism and cell signaling","volume":"27","author":"Harada","year":"2009","journal-title":"J.\u00a0Bone Miner. Metab."},{"key":"10.1016\/j.bpj.2014.11.3460_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bpj.2014.11.3460_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/humu.21636","article-title":"Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias","volume":"33","author":"Foldynova-Trantirkova","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bpj.2014.11.3460_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrm3528","article-title":"Exploring mechanisms of FGF signalling through the lens of structural biology","volume":"14","author":"Goetz","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bpj.2014.11.3460_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M","article-title":"FGFs, heparan sulfate and FGFRs: complex interactions essential for development","volume":"22","author":"Ornitz","year":"2000","journal-title":"BioEssays"},{"key":"10.1016\/j.bpj.2014.11.3460_bib17","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1186\/gb-2001-2-3-reviews3005","article-title":"Fibroblast growth factors","volume":"2","author":"Ornitz","year":"2001","journal-title":"Genome Biol."},{"key":"10.1016\/j.bpj.2014.11.3460_bib18","doi-asserted-by":"crossref","first-page":"14476","DOI":"10.1073\/pnas.1203201109","article-title":"Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2","volume":"109","author":"Greulich","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bpj.2014.11.3460_bib19","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1158\/1078-0432.CCR-09-0786","article-title":"Targeting RET receptor tyrosine kinase activation in cancer","volume":"16","author":"Phay","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bpj.2014.11.3460_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.urolonc.2011.12.001","article-title":"Fibroblast growth factor receptor-3 in urothelial tumorigenesis","volume":"31","author":"Iyer","year":"2013","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.bpj.2014.11.3460_bib21","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1021\/ja910692u","article-title":"Measuring the energetics of membrane protein dimerization in mammalian membranes","volume":"132","author":"Chen","year":"2010","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.bpj.2014.11.3460_bib22","doi-asserted-by":"crossref","first-page":"ra86","DOI":"10.1126\/scisignal.2001195","article-title":"The extracellular domain of\u00a0fibroblast growth factor receptor 3 inhibits ligand-independent dimerization","volume":"3","author":"Chen","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bpj.2014.11.3460_bib23","doi-asserted-by":"crossref","first-page":"8650","DOI":"10.1021\/ac301776j","article-title":"Production of plasma membrane vesicles with chloride salts and their utility as a cell membrane mimetic for biophysical characterization of membrane protein interactions","volume":"84","author":"Del Piccolo","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bpj.2014.11.3460_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ab.2013.12.027","article-title":"Uninduced high-yield\u00a0bacterial expression of fluorescent proteins","volume":"449","author":"Sarabipour","year":"2014","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bpj.2014.11.3460_bib25","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1021\/ac800616u","article-title":"Quantitative measurements of protein interactions in a crowded cellular environment","volume":"80","author":"Li","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bpj.2014.11.3460_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0006-3495(79)85171-1","article-title":"An analytic solution to the F\u00f6rster energy transfer problem in two dimensions","volume":"28","author":"Wolber","year":"1979","journal-title":"Biophys.\u00a0J."},{"key":"10.1016\/j.bpj.2014.11.3460_bib27","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.bpj.2014.01.039","article-title":"The FRET signatures of noninteracting proteins in membranes: simulations and experiments","volume":"106","author":"King","year":"2014","journal-title":"Biophys.\u00a0J."},{"key":"10.1016\/j.bpj.2014.11.3460_bib28","doi-asserted-by":"crossref","first-page":"13183","DOI":"10.1021\/bi061288t","article-title":"Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers","volume":"45","author":"Evers","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bpj.2014.11.3460_bib29","series-title":"Data reduction and error analysis for the physical sciences","author":"Bevington","year":"1969"},{"key":"10.1016\/j.bpj.2014.11.3460_bib30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1126\/science.982044","article-title":"Plasma membrane vesiculation: a new technique for isolation of plasma membranes","volume":"194","author":"Scott","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.bpj.2014.11.3460_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1242\/jcs.35.1.245","article-title":"Plasma membrane vesiculation in 3T3 and SV3T3 cells. II. Factors affecting the process of vesiculation","volume":"35","author":"Scott","year":"1979","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.bpj.2014.11.3460_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1242\/jcs.35.1.229","article-title":"Plasma membrane vesiculation in 3T3 and SV3T3 cells. I. Morphological and biochemical characterization","volume":"35","author":"Scott","year":"1979","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.bpj.2014.11.3460_bib33","doi-asserted-by":"crossref","first-page":"e46678","DOI":"10.1371\/journal.pone.0046678","article-title":"Direct assessment of the effect of the Gly380Arg achondroplasia mutation on FGFR3 dimerization using quantitative imaging FRET","volume":"7","author":"Placone","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bpj.2014.11.3460_bib34","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.bbamem.2014.03.001","article-title":"Strong dimerization of wild-type ErbB2\/Neu transmembrane domain and the oncogenic Val664Glu mutant in mammalian plasma membranes","volume":"1838","author":"Placone","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bpj.2014.11.3460_bib35","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.bbamem.2013.03.022","article-title":"Glycophorin A transmembrane domain dimerization in plasma membrane vesicles derived from CHO, HEK 293T, and A431 cells","volume":"1828","author":"Sarabipour","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bpj.2014.11.3460_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bpj.2013.05.053","article-title":"FGFR3 transmembrane domain interactions persist in the presence of its extracellular domain","volume":"105","author":"Sarabipour","year":"2013","journal-title":"Biophys.\u00a0J."},{"key":"10.1016\/j.bpj.2014.11.3460_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0006-3495(21)00380-5","article-title":"Quantitative characterization of the lateral distribution of membrane proteins within the lipid bilayer","volume":"37","author":"Freire","year":"1982","journal-title":"Biophys.\u00a0J."},{"key":"10.1016\/j.bpj.2014.11.3460_bib38","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/pro.5560021002","article-title":"Disulfide bonds and the stability of globular proteins","volume":"2","author":"Betz","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.bpj.2014.11.3460_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1110\/ps.073134408","article-title":"Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain","volume":"17","author":"McAuley","year":"2008","journal-title":"Protein Sci."}],"container-title":["Biophysical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006349514046736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006349514046736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T03:15:57Z","timestamp":1651029357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006349514046736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0006349514046736"],"URL":"https:\/\/doi.org\/10.1016\/j.bpj.2014.11.3460","relation":{},"ISSN":["0006-3495"],"issn-type":[{"value":"0006-3495","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Thanatophoric Dysplasia Type I Mutations on FGFR3 Dimerization","name":"articletitle","label":"Article Title"},{"value":"Biophysical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpj.2014.11.3460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Biophysical Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}